Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Basilea shares dented after FDA digs in on antibiotic PhIII rule
Basilea shares dented after FDA digs in on antibiotic PhIII rule
Basilea shares dented after FDA digs in on antibiotic PhIII rule
Submitted by
admin
on August 21, 2013 - 11:16am
Source:
Fierce Biotech
News Tags:
Basilea
ceftobiprole
FDA
antibiotics
Headline:
Basilea shares dented after FDA digs in on antibiotic PhIII rule
Do Not Allow Advertisers to Use My Personal information
